nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclopirox—Nail disorder—Floxuridine—stomach cancer	0.069	0.0855	CcSEcCtD
Ciclopirox—Burning sensation—Mitomycin—stomach cancer	0.0506	0.0626	CcSEcCtD
Ciclopirox—ATP1A1—gall bladder—stomach cancer	0.0381	0.198	CbGeAlD
Ciclopirox—Application site reaction—Fluorouracil—stomach cancer	0.0312	0.0386	CcSEcCtD
Ciclopirox—Dry skin—Floxuridine—stomach cancer	0.0298	0.0369	CcSEcCtD
Ciclopirox—Nail disorder—Fluorouracil—stomach cancer	0.0225	0.0279	CcSEcCtD
Ciclopirox—ATP1A1—hematopoietic system—stomach cancer	0.0216	0.112	CbGeAlD
Ciclopirox—Alopecia—Floxuridine—stomach cancer	0.0199	0.0246	CcSEcCtD
Ciclopirox—ATP1A1—epithelium—stomach cancer	0.0197	0.103	CbGeAlD
Ciclopirox—Erythema—Floxuridine—stomach cancer	0.0196	0.0242	CcSEcCtD
Ciclopirox—ATP1A1—smooth muscle tissue—stomach cancer	0.019	0.0989	CbGeAlD
Ciclopirox—ATP1A1—pancreas—stomach cancer	0.0176	0.0914	CbGeAlD
Ciclopirox—Nail disorder—Docetaxel—stomach cancer	0.0163	0.0201	CcSEcCtD
Ciclopirox—Nail disorder—Capecitabine—stomach cancer	0.0157	0.0195	CcSEcCtD
Ciclopirox—Alopecia—Mitomycin—stomach cancer	0.0156	0.0193	CcSEcCtD
Ciclopirox—Erythema—Mitomycin—stomach cancer	0.0154	0.019	CcSEcCtD
Ciclopirox—ATP1A1—lymphoid tissue—stomach cancer	0.0152	0.079	CbGeAlD
Ciclopirox—Burning sensation—Docetaxel—stomach cancer	0.0152	0.0188	CcSEcCtD
Ciclopirox—ATP1A1—digestive system—stomach cancer	0.015	0.0781	CbGeAlD
Ciclopirox—Dermatitis contact—Fluorouracil—stomach cancer	0.0144	0.0179	CcSEcCtD
Ciclopirox—ATP1A1—bone marrow—stomach cancer	0.0138	0.072	CbGeAlD
Ciclopirox—ATP1A1—endocrine gland—stomach cancer	0.0124	0.0645	CbGeAlD
Ciclopirox—Nail disorder—Methotrexate—stomach cancer	0.0117	0.0145	CcSEcCtD
Ciclopirox—ATP1A1—liver—stomach cancer	0.0112	0.0582	CbGeAlD
Ciclopirox—Nail disorder—Epirubicin—stomach cancer	0.011	0.0136	CcSEcCtD
Ciclopirox—Burning sensation—Methotrexate—stomach cancer	0.0109	0.0135	CcSEcCtD
Ciclopirox—Pain—Mitomycin—stomach cancer	0.0107	0.0133	CcSEcCtD
Ciclopirox—Burning sensation—Epirubicin—stomach cancer	0.0102	0.0127	CcSEcCtD
Ciclopirox—Nail disorder—Doxorubicin—stomach cancer	0.0102	0.0126	CcSEcCtD
Ciclopirox—Rash—Floxuridine—stomach cancer	0.0101	0.0125	CcSEcCtD
Ciclopirox—Skin exfoliation—Docetaxel—stomach cancer	0.0101	0.0125	CcSEcCtD
Ciclopirox—Dermatitis—Floxuridine—stomach cancer	0.0101	0.0125	CcSEcCtD
Ciclopirox—Headache—Floxuridine—stomach cancer	0.01	0.0124	CcSEcCtD
Ciclopirox—Skin exfoliation—Capecitabine—stomach cancer	0.00975	0.0121	CcSEcCtD
Ciclopirox—Dry skin—Fluorouracil—stomach cancer	0.00973	0.012	CcSEcCtD
Ciclopirox—Burning sensation—Doxorubicin—stomach cancer	0.00948	0.0117	CcSEcCtD
Ciclopirox—ATP1A1—lymph node—stomach cancer	0.00857	0.0446	CbGeAlD
Ciclopirox—Eye pain—Capecitabine—stomach cancer	0.00821	0.0102	CcSEcCtD
Ciclopirox—Rash—Mitomycin—stomach cancer	0.00791	0.00979	CcSEcCtD
Ciclopirox—Dermatitis—Mitomycin—stomach cancer	0.0079	0.00978	CcSEcCtD
Ciclopirox—Headache—Mitomycin—stomach cancer	0.00785	0.00972	CcSEcCtD
Ciclopirox—Skin exfoliation—Methotrexate—stomach cancer	0.00726	0.00899	CcSEcCtD
Ciclopirox—Face oedema—Capecitabine—stomach cancer	0.00716	0.00886	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Epirubicin—stomach cancer	0.00712	0.00881	CcSEcCtD
Ciclopirox—Dermatitis contact—Epirubicin—stomach cancer	0.00703	0.00871	CcSEcCtD
Ciclopirox—Dry skin—Docetaxel—stomach cancer	0.00702	0.00869	CcSEcCtD
Ciclopirox—Immune system disorder—Irinotecan—stomach cancer	0.00692	0.00857	CcSEcCtD
Ciclopirox—Dry skin—Capecitabine—stomach cancer	0.0068	0.00841	CcSEcCtD
Ciclopirox—Skin exfoliation—Epirubicin—stomach cancer	0.00679	0.00841	CcSEcCtD
Ciclopirox—Alopecia—Irinotecan—stomach cancer	0.00677	0.00838	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Doxorubicin—stomach cancer	0.00658	0.00815	CcSEcCtD
Ciclopirox—Dermatitis contact—Doxorubicin—stomach cancer	0.00651	0.00805	CcSEcCtD
Ciclopirox—Alopecia—Fluorouracil—stomach cancer	0.00649	0.00803	CcSEcCtD
Ciclopirox—Erythema—Fluorouracil—stomach cancer	0.00639	0.00791	CcSEcCtD
Ciclopirox—Skin exfoliation—Doxorubicin—stomach cancer	0.00629	0.00778	CcSEcCtD
Ciclopirox—Eczema—Epirubicin—stomach cancer	0.00575	0.00712	CcSEcCtD
Ciclopirox—Eye pain—Epirubicin—stomach cancer	0.00572	0.00708	CcSEcCtD
Ciclopirox—Eczema—Doxorubicin—stomach cancer	0.00532	0.00658	CcSEcCtD
Ciclopirox—Eye pain—Doxorubicin—stomach cancer	0.00529	0.00655	CcSEcCtD
Ciclopirox—Face oedema—Epirubicin—stomach cancer	0.00499	0.00617	CcSEcCtD
Ciclopirox—Immune system disorder—Docetaxel—stomach cancer	0.00479	0.00592	CcSEcCtD
Ciclopirox—Dry skin—Epirubicin—stomach cancer	0.00473	0.00586	CcSEcCtD
Ciclopirox—Alopecia—Docetaxel—stomach cancer	0.00468	0.0058	CcSEcCtD
Ciclopirox—Pain—Irinotecan—stomach cancer	0.00466	0.00576	CcSEcCtD
Ciclopirox—Immune system disorder—Capecitabine—stomach cancer	0.00463	0.00574	CcSEcCtD
Ciclopirox—Face oedema—Doxorubicin—stomach cancer	0.00461	0.00571	CcSEcCtD
Ciclopirox—Erythema—Docetaxel—stomach cancer	0.00461	0.00571	CcSEcCtD
Ciclopirox—Alopecia—Capecitabine—stomach cancer	0.00453	0.00561	CcSEcCtD
Ciclopirox—Erythema—Capecitabine—stomach cancer	0.00447	0.00553	CcSEcCtD
Ciclopirox—Pain—Fluorouracil—stomach cancer	0.00446	0.00552	CcSEcCtD
Ciclopirox—Dry skin—Doxorubicin—stomach cancer	0.00438	0.00542	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.0039	0.00483	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00378	0.00467	CcSEcCtD
Ciclopirox—Pruritus—Fluorouracil—stomach cancer	0.00369	0.00457	CcSEcCtD
Ciclopirox—Skin disorder—Docetaxel—stomach cancer	0.00366	0.00453	CcSEcCtD
Ciclopirox—Skin disorder—Capecitabine—stomach cancer	0.00354	0.00438	CcSEcCtD
Ciclopirox—Immune system disorder—Methotrexate—stomach cancer	0.00345	0.00427	CcSEcCtD
Ciclopirox—Rash—Irinotecan—stomach cancer	0.00343	0.00425	CcSEcCtD
Ciclopirox—Dermatitis—Irinotecan—stomach cancer	0.00343	0.00425	CcSEcCtD
Ciclopirox—Headache—Irinotecan—stomach cancer	0.00341	0.00422	CcSEcCtD
Ciclopirox—Alopecia—Methotrexate—stomach cancer	0.00337	0.00418	CcSEcCtD
Ciclopirox—Erythema—Methotrexate—stomach cancer	0.00332	0.00411	CcSEcCtD
Ciclopirox—Rash—Fluorouracil—stomach cancer	0.00329	0.00407	CcSEcCtD
Ciclopirox—Dermatitis—Fluorouracil—stomach cancer	0.00329	0.00407	CcSEcCtD
Ciclopirox—Headache—Fluorouracil—stomach cancer	0.00327	0.00404	CcSEcCtD
Ciclopirox—Immune system disorder—Epirubicin—stomach cancer	0.00323	0.004	CcSEcCtD
Ciclopirox—Pain—Docetaxel—stomach cancer	0.00322	0.00398	CcSEcCtD
Ciclopirox—Alopecia—Epirubicin—stomach cancer	0.00316	0.00391	CcSEcCtD
Ciclopirox—Pain—Capecitabine—stomach cancer	0.00312	0.00386	CcSEcCtD
Ciclopirox—Erythema—Epirubicin—stomach cancer	0.00311	0.00385	CcSEcCtD
Ciclopirox—Immune system disorder—Doxorubicin—stomach cancer	0.00299	0.0037	CcSEcCtD
Ciclopirox—Alopecia—Doxorubicin—stomach cancer	0.00292	0.00362	CcSEcCtD
Ciclopirox—Erythema—Doxorubicin—stomach cancer	0.00288	0.00356	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00281	0.00348	CcSEcCtD
Ciclopirox—Pruritus—Docetaxel—stomach cancer	0.00266	0.0033	CcSEcCtD
Ciclopirox—Skin disorder—Methotrexate—stomach cancer	0.00264	0.00326	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00263	0.00326	CcSEcCtD
Ciclopirox—Pruritus—Capecitabine—stomach cancer	0.00258	0.00319	CcSEcCtD
Ciclopirox—Skin disorder—Epirubicin—stomach cancer	0.00247	0.00305	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00243	0.00301	CcSEcCtD
Ciclopirox—Rash—Docetaxel—stomach cancer	0.00237	0.00294	CcSEcCtD
Ciclopirox—Dermatitis—Docetaxel—stomach cancer	0.00237	0.00294	CcSEcCtD
Ciclopirox—Headache—Docetaxel—stomach cancer	0.00236	0.00292	CcSEcCtD
Ciclopirox—Pain—Methotrexate—stomach cancer	0.00232	0.00287	CcSEcCtD
Ciclopirox—Rash—Capecitabine—stomach cancer	0.0023	0.00284	CcSEcCtD
Ciclopirox—Dermatitis—Capecitabine—stomach cancer	0.0023	0.00284	CcSEcCtD
Ciclopirox—Headache—Capecitabine—stomach cancer	0.00228	0.00283	CcSEcCtD
Ciclopirox—Skin disorder—Doxorubicin—stomach cancer	0.00228	0.00282	CcSEcCtD
Ciclopirox—Pain—Epirubicin—stomach cancer	0.00217	0.00269	CcSEcCtD
Ciclopirox—Pain—Doxorubicin—stomach cancer	0.00201	0.00249	CcSEcCtD
Ciclopirox—Pruritus—Methotrexate—stomach cancer	0.00192	0.00238	CcSEcCtD
Ciclopirox—Pruritus—Epirubicin—stomach cancer	0.0018	0.00222	CcSEcCtD
Ciclopirox—Rash—Methotrexate—stomach cancer	0.00171	0.00212	CcSEcCtD
Ciclopirox—Dermatitis—Methotrexate—stomach cancer	0.00171	0.00212	CcSEcCtD
Ciclopirox—Headache—Methotrexate—stomach cancer	0.0017	0.0021	CcSEcCtD
Ciclopirox—Pruritus—Doxorubicin—stomach cancer	0.00166	0.00206	CcSEcCtD
Ciclopirox—Rash—Epirubicin—stomach cancer	0.0016	0.00198	CcSEcCtD
Ciclopirox—Dermatitis—Epirubicin—stomach cancer	0.0016	0.00198	CcSEcCtD
Ciclopirox—Headache—Epirubicin—stomach cancer	0.00159	0.00197	CcSEcCtD
Ciclopirox—Rash—Doxorubicin—stomach cancer	0.00148	0.00183	CcSEcCtD
Ciclopirox—Dermatitis—Doxorubicin—stomach cancer	0.00148	0.00183	CcSEcCtD
Ciclopirox—Headache—Doxorubicin—stomach cancer	0.00147	0.00182	CcSEcCtD
